chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Ruptured pustules in generalized pattern to both arms and legs as well as face and continued complaint of itching. Benadryl given. Ancef/Cephalexin given as a precaution for systemic infection. General vaccinia.
Information regarding Flumist nasal solution was received from a healthcare professional regarding a 60 year old male who experienced slurred speech and saw spots before his eyes. At 60 years of age, the patient received a dose of 10/22/2003. The patient's concurrent illnesses include cardiac failure congestive, chronic obstructive airways disease, alcoholism, and alcohol intoxication. Indication for Flumist was immunization. Product was administered on 10/22/03. Dose regimen was 0.5mL 1 time per day (IN). Concomitant therapy included Lipitor, Vasotec, Acetylsalicylic Acid, Tenormin and sublingual NTG. The patient developed slurred speech and saw spots before his eyes on 10/22/03. No additional information was available at the date of this report.
Moderna COVID-19 Vaccine EUA. Aches, chills, fever, nausea, diarreah, numbness in fingertips, tingling or numbness in scalp.
vaccinated on 5/14/21 & 6/4/21 and diagnosed in hospital on 8/7/2021 with  COVID-19
Post vax, child tolerated well with crying. At about 13:10, child taken from lying on the floor horizontally to table, pale. Child was picked up, placed sitting on table and began crying. Child's little brother (infant) was receiving vaccines at the time. The doctor was called to child's side. Vital signs: pulse-102; resp-30; BP-92/50; pulse ox-96-97. Child occasionally crying "I want to go home".
Hives all over body, swelling of the lips  fever for first 2 days Benadryl and Prednisolone  outcome - resolved
Reported by mother.  When he got his vaccine,  he went home and had no reaction.  The next morning he had a fever of 103, and gave her Tylenol chewable.  The following day he has no fever, in the early at 4:00 AM he woke up with pain on his chest.  He said that he felt weird, tightness on his chest and he could not actually describe it, said it was in the middle of his chest.  It was uncomfortable but uncomfortable and was worried.  They observed him, the pain didn't go away, just on the chest.  If he tried to sit up he felt better, but when he laid down the pain was always there.  Around 3:00 PM she brought him to the ER and had tests run, and all tests were okay.  His EKG showed ST-elevations and inflammation of the heart.  He had an US of the heart and was discharged home this morning.  He has to be seen by his PCP to be referred to a cardiologist.  He was given some medications and is sleeping right now.  He has an APT with his PCP on 6/9/21.   He was sent home to take Ibuprofen.
patient called a couple of days later, explained to me  she passed out, her eyes rolling in the back of her head, was unconscious and husband was scared, called 911 ambulance took her to ER , patient is home and appears to be doing well
Patient is a 74-year-old female with history of hypertension, CAD, HFpEF, COPD on 5 L home oxygen, diabetes who presented to the ER after a fall at home.  Patient reported to have profuse foul-smelling diarrhea previous to this.  In the ER patient was desatting requiring 6 L nasal cannula which worsened to requiring high-flow nasal cannula. CXR showed mild patchy atelectasis superimposed upon chronic pulmonary fibrosis. Patient found to be COVID-19 positive and was admitted for acute hypoxic respiratory failure requiring BiPAP. Pulm and ID on consult. Pt having worsening azotemia with hypernatremia and hyperkalemia and poor oral intake, Nephrology consulted. Continues to be hypernatremic on freewater and D5W. Code status changed to DNAR after speaking to daughter.  patient requiring high-flow nasal cannula with taking breaks on BiPAP.  Patient's hypoxia advanced and requiring nearly persistent BiPAP.  Pulmonology and Infectious Disease were consulted.  Patient's Decadron was increased to 6 mg b.i.d. And Baricitinib was initiated by Infectious Disease.  Patient was already on Remdesivir.  Patient had some CO2 retention on ABG, after 48 hr patient's bicarb continue to worsen so ABG is being repeated.  Patient has poor oral intake and sodium increased to 156 placed on D5W with good effect.  Nasogastric tube was placed and patient was started on tube feeds.  Patient on persistent BiPAP with oxygen requirements improving.  Patient still having trouble transitioning to high-flow nasal cannula.  On January 24th patient did vomit with BiPAP it was removed very quickly patient is alert.  Patient was initiated on cefepime and Flagyl as prophylaxis for aspiration pneumonia.  NG tube was placed to suction, D-dimer returned greater than 15,000. CT angio of the chest negative for PE.  Patient started to improve but improvement was only for about 2 hr on high-flow than patient was back on BiPAP.  The following day family elected for hospice care.  Patient's NG tube was transitioned back to tube feeds but then discontinued in anticipation of discharge home on hospice.  Patient will be discharged on BiPAP and BiPAP were removed in the home.  Patient is being discharged home on January 28, 2022 in grave condition.
my period began 16 days early/4 days after the Covid 19 vaccination my period began 16 days early; bled for 21 days total. (My regular periods are 5 days long); This is a spontaneous report form a contactable consumer (patient). A 44-year-old non pregnant female patient received bnt162b2 (PFIZER-BIONTEC COVID-19 VACCINE, formulation: solution for injection) via an unspecified route of administration in arm left on 11Apr2021 18:45 (at the age of 44-years-old) (Batch/Lot number: ER7533, Expiration Date: was not reported) as DOSE 1 single for covid-19 immunisation. The patient's medical history was reported as none. concomitant medication included the contraceptive pill. Patient reported 4 days after the Covid 19 vaccination her period began 16 days early on 15Apr2021 07:30 at. As she on the pill her menstruation is regulated. She was 5 days into a new pill pack when the bleeding began (which means she last period had only finished 5 days previously) and she bled for 21 days total. (Her regular periods are 5 days long) on an unspecified date in 2021. This is highly unusual, she has been on the pill for most of my adult life and have never had a breakthrough bleed during the month. She has never experienced an extended bleed. Patient had not received any treatment. Patient had no allergies. Vaccination facility type was reported as School or Student Health Clinic. Patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. Patient received contraceptive pill within 2 weeks of vaccination. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, he was not tested for COVID-19. The seriousness of the events was reported as non-serious. The outcome of the event my period began 16 days early/4 days after the Covid 19 vaccination my period began 16 days early was resolved on an unspecified date in Apr2021 and other event was reported as unknown.   No Follow-up attempts are needed. No further information is expected.
1 month after the vaccine I got a very heavy period. I continued to bleed for an additional 30 days into my next period.  I had large clots, and heavy bleeding. My next period was also heavy and is currently ongoing.
30 minutes after infection, strong wave of confusion and cold/numb fingers, coldness in stomach, extreme fatigue. 24 hours later - abdominal pain and nausea
Exhaustion and  was given  blood test, and given test for HIV, Eventually was told he had the Antibodies for HIV.
my menstrual cycle has expanded from 28 days to 44 -52 days.
Fever, chills, headache, and exhaustion that lasted for almost 24 hours. I took ibuprofen, drank water, and slept. The symptoms were no longer present the next day.
0.25ml Fluviron given. Rec for >4yrs. Marked on box not actual vial. No Reaction
This spontaneous case was reported by a pharmacist and describes the occurrence of PAIN IN EXTREMITY (slightly sore arm) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 vaccination. No known allergies to food, medication and other products was reported. Patient was not diagnosed or tested positive for COVID-19. There was no diagnosed acute illness at the time of vaccination and up to one month before. There was no chronic or long-standing health conditions. Concomitant products included ACETYLSALICYLIC ACID (ASPIRIN 81) for Clot blood. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (slightly sore arm). At the time of the report, PAIN IN EXTREMITY (slightly sore arm) outcome was unknown. The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No treatment information was reported. This case was linked to MOD-2022-544354 (Patient Link).
pt recv vax 3PM & 6PM mouth gum-cheeks felt as if blisters were trying to break through mucous membrane like had eaten red/hot pepper;7PM eyes became red felt had gravel under eye lids;9PM felt throat muscles getting tight-to ER;given DPH;
Patient reported swelling, itching, hard lump 3.5x1.5" area. Fiery hot & lender. Swelling went down days later, patient reports 5 days later site is pink and about 0.5" smaller.
Blacked out; Anaphylactic reaction; A spontaneous report was received from a consumer concerning a patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced anaphylactic reaction and blacked out.  The patient's medical history was not provided. No relevant concomitant medications were reported.   On unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection.   On unknown date, after receiving the vaccine, the patient experienced an anaphylactic reaction and blacked out. The patient was placed on a ventilator for the events.  Action taken with mRNA-1273 in response to the event was not reported.   The outcome for the event, anaphylactic reaction and blacked out, was unknown.; Reporter's Comments: This case concerns a patient of unknown of age and gender. The medical history is not provided. On unknown date after receiving their first of two planned doses of mRNA-1273 (Lot unknown), the patient experienced medically significant events of Anaphylactic reaction and Loss of consciousness. Treatment included placed on a ventilator for the events. Very limited information regarding this event has been provided at this time.  Based on the current available information and temporal association between the use of the product and the onset of the events, a causal relationship cannot be excluded and the events are considered possibly related to the vaccine.
tested positive for COVID; headaches; shortness of breath; bodyache; felt fatigued; A spontaneous report was received from a healthcare professional concerning a 33-years-old  female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events headaches, shortness of breath, body aches, felt fatigued, tested positive for covid.  The patient's medical history was not provided. Concomitant medications reported were birth control medication.  On 23 Dec 2020, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 011J20A) ivia unknown route for prophylaxis of COVID-19 infection.  On 20 Jan 2021, prior to the onset of the events the patient received their second of two planned doses of mRNA-1273 (lot/batch: 042L20A) via unknown route for prophylaxis of COVID-19 infection.  On 9 Feb 2021, the patient experienced the events- headache, shortness of breath, body aches and felt fatigued. On 11 Feb 2021, the patient  tested positive for covid. She stated the symptoms subsided on their own  On 11 Feb 2021, the lab data performed included- Rapid test (negative) and PCR test (positive).  No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events- headaches,shortness of breath, body aches,  fatigue and Covid 19 positive- was Recovering/Resolving.
Upon arrival to the ED patient was tachycardic with rates in the 110s to 120s, febrile at 101.7, blood pressure was 130s over 90s, requiring 2 to 3 L of oxygen to maintain oxygen saturations greater than 90%. She was noted to be in atrial fibrillation with RVR and EKG showed no acute ischemic findings.  Troponin is negative, BNP elevated in the setting of known congestive heart failure with a EF in the 20 to 30% range. She received tylenol for fever, metoprolol x3 with adequate rate control achieved.  Fever likely r/t to immune response generated by COVID-19 vaccine which she received earlier that day, normal white count, no infiltrate on CXR, lactate normal, blood culture x2 pending. She was given Lasix 40 mg. Patient admitted for further diuresis and rate control.
Severe chills, Extreme Fatigue, Severe muscle aches, Rash developing at injection site
No adverse event known.  Patient was given vaccine that is not FDA approved for pediatric use in error.
Respiratory Problems; This is a spontaneous report from a contactable consumer or other non hcp. This is report 2 of 2. A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: Not Provided), via an unspecified route of administration on an unspecified date as dose number unknown, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient experienced respiratory problems. The outcome of the event was unknown.  No follow-up attempts are possible. Information about lot/batch number cannot be obtained
THEY TOLD ME THAT THEY WERE GOING TO PUT MY SON A SHOT BUT, THEY NEVER TOLD ME WHICH ONE THEY WERE GOING TO PUT MY SON.
It was reported that a 22 year old femlae received a dose of Yellow fever vaccine on 6/12/02. The pt compalined of intense localized aching to left upper injection site on 6/13/02 which lasted over 24 hrs. At 2.5mm erythematous induration noted to the left upper arm. The pt was seen by a physician on 6/14/02. Her temp was 97.8 deg F and blood pressure was 101/61. She recovered from the event.
Itching; Red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching) and ERYTHEMA (Red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching) and ERYTHEMA (Red). At the time of the report, PRURITUS (Itching) and ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
mom brough pt to ER "my baby is sick", pt unresponsive, mottled, blue; t109 R; resuscitation failed;
Persistent pruritic rash; This case was reported by a physician and described the occurrence of itchy rash in a adult patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of no adverse event (1st dose received in March 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, less than 9 months after receiving Shingrix, the patient experienced itchy rash. The patient was treated with steroids nos (Steroids). On an unknown date, the outcome of the itchy rash was not recovered/not resolved.   It was unknown if the reporter considered the itchy rash to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The age group was not reported but was captured as an adult as per vaccine indication.  The patient received second dose a few months after the first dose and developed a persistent pruritic rash. The patient received steroids due to this. The patient stated that his/her symptoms might have flared again after receiving Fluzone a few months after the second dose of Shingrix. The physician declined follow-up and did not have the time to provide additional information.
ADV EFFECTS: HEADACHE, EXTREME FATIGUE, TINGLING ON ARM/SHOULDER/LEG/FEET, BUTTERFLY RASH ON FACE,HOT FLASH, WHEEZING,  CHILL. PATIENT WAS ON TYLENOL AND IT HELPED WITH THE SYMPTOMS
MOM CALLED TODAY (03/23/07 11:30AM).CLAIMS CHILD HAS FEVER STARTED FEVER OF 38DEGREES CELSIUS AS OF THIS MORNING.  SHE NOTICED TODAY THAT RIGHT ARM HAS PAIN, RED CIRCLE, TIGHT IN TEXTURE.  ALSO THAT SHE HAS A TUMMY ACHE. INFORMED MOM TO CALL DOCTOR FOR FURTHER EVALUATION.  SPOKE TO MOM FEW MINUTES LATER, INFORMED ME THAT DOCTOR TOLD HER FEVER NORMAL, AS FOR RED NOT SURE BUT TO MONITOR AND IF FEVER DOES NOT GO AWAY IN 24HRS TO BRING IN. MOTHER GAVE MOTRIN.
for weeks every morning when i got up I could not raise my right arm.  Several weeks after the vaccine I would wake up nightly, several times during each night with tingling fingers. Both hands. At the end of March thinking not knowing why my hands were tingling I went to the chiropractor. After going twice a week for over a month I had some relief. Then my thumbs started locking up, mostly in the morning. After a couple weeks of that happening, my right hand continued to be tingling and my left wrist and thumb are very sore. Sometimes to the touch. My fingers are swollen to the point that i cant wear my rings. Some days when I raise my right arm  I have pain at injection spot
she was sick; Caller got the 1st dose of Vaccine on the 19Jan2021, 2weeks later She tested positive with covid-19 with minor symptoms.; She tested positive with covid-19; This is a spontaneous report from a Pfizer-sponsored program. A contactable female consumer (patient) of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/lot number: Unknown, Expiry Date: Unknown,) via an unspecified route of administration on 19Jan2021 at single dose for COVID-19 immunisation. It was unspecified covid vaccine a Pfizer product and covid vaccine manufacturer was also unspecified. There was no lot number because caller was unwilling to complete the report. The patient's medical history and concomitant medications were not reported. The patient experienced caller got the 1st dose of vaccine on the 19Jan2021, 2 weeks later she tested positive with covid-19 with minor symptoms and she tested positive with covid-19 in 2021 and she was sick. There was product complaint. She is calling about the covid vaccine. Patient stated she got the 1st dose of vaccine on the 19Jan2021, 2 weeks later she tested positive with covid-19 with minor symptoms. She is fine now, but she missed the second dose. She tried to get with the agency since she missed the 2nd dose which supposedly is on the 09Feb2021. She is stuck in (state) trying to get the 2nd dose. Now she is having a hard time, in getting the second dose. She needs to find a facility that has a second dose of Pfizer. Some facilities say that they are not giving the Pfizer anymore. She did call the agency, because some people told her she can't get second dose, the agency told her that is incorrect, she absolutely cannot get the second dose only if she had treatment. She states that she had mild symptoms and got no treatment, she is 10 days over and free to get second dose. Caller states that she has been searching for a second dose. She called the local health department and told them that she missed her second dose, because she was sick. She needs a second dose of Pfizer. She was told not to get (another brand vaccine name) since she had a first dose of Pfizer. When queried for a safety report, she states that the first lady she spoke to was really nice. She's the one who hooked her up on this line, she didn't call the line for herself, her purpose of calling was absolutely not to go through a safety report. She wanted her question addressed.  She wants to know where in (state name) or in general vicinity can she get a second dose. She declined the safety report. The patient underwent lab tests and procedures which included sars-cov-2 test positive in 2021. The outcome event was recovered.   Information regarding Lot/batch number has been requested.
Was not feeling too good; Body pain; Headache; Arm hurt pretty bad; Shivering; Night of 12apr2021 was pretty bad; Went to bed at 930 which is not him; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Night of 12apr2021 was pretty bad), SLEEP DISORDER (Went to bed at 930 which is not him), MALAISE (Was not feeling too good), PAIN (Body pain) and HEADACHE (Headache) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025b21a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 12-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Apr-2021, the patient experienced FEELING ABNORMAL (Night of 12apr2021 was pretty bad), SLEEP DISORDER (Went to bed at 930 which is not him), HEADACHE (Headache), VACCINATION SITE PAIN (Arm hurt pretty bad) and CHILLS (Shivering). On 13-Apr-2021, the patient experienced PAIN (Body pain). On an unknown date, the patient experienced MALAISE (Was not feeling too good). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 13-Apr-2021, FEELING ABNORMAL (Night of 12apr2021 was pretty bad), SLEEP DISORDER (Went to bed at 930 which is not him), HEADACHE (Headache), VACCINATION SITE PAIN (Arm hurt pretty bad) and CHILLS (Shivering) had resolved. At the time of the report, MALAISE (Was not feeling too good) and PAIN (Body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Shakes; Vomiting; Chills; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 11May2021 at 17:15 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medication included unspecified birth control medication from an unknown date and unknown if ongoing. On 12May2021 at 01:30, approximately 7 hours after receiving the shot (also reported as around 01:00), the patient experienced vomiting, chills and shakes. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events vomiting, chills and shakes were resolving at the time of the report.   No follow-up attempts are needed. No further information is expected.
Two days post vaccine, the patient developed a raised area at injection site that continued around the shoulder towards the back. The patient also complained of soreness. She was treated with massage.